Neuroscience News

BRAIN Initiative Research Leads to FDA Approval of Adaptive Deep Brain Stimulation for Parkinson’s Disease

NIH BRAIN Initiative-funded research is key to FDA approval of personalized DBS for Parkinson’s  

Deep brain stimulation (DBS) has been used for decades to treat Parkinson’s disease in people who no longer benefit from medications meant to restore levels of the brain chemical dopamine that drives this condition. And although DBS has helped people living with the uncontrollable body movements typical of Parkinson’s, many people have limited benefit and experience side effects.

BRAIN at 10: A View from the National Institute of Biomedical Imaging and Bioengineering

The BRAIN Initiative is marking a milestone—10 years of advancing neuroscience and neurotechnology research by funding innovative projects. As part of a rotating series of blog posts, the directors of the BRAIN Initiative-partnering Institutes and Centers share their voice and perspectives on the impact BRAIN has made on their respective missions—and vice versa. 

By  Bruce J. Tromberg, Ph.D., Director, National Institute of Biomedical Imaging and Bioengineering 

Export to:
A maximum of 400 records can be exported.